Nona Biosciences, a global leader in technology innovation and antibody discovery and development solutions, has recently announced a strategic partnership with GeneQuantum Healthcare. The collaboration aims to advance the early discovery of next-generation bioconjugates, combining Nona Biosciences' Harbour Mice® platform and advanced technologies with GeneQuantum's exclusive iLDC (intelligent Ligase-dependent Conjugation) and iGDC (intelligent Glycotransferase-dependent conjugation) platforms.
The partnership will synergize the strengths of both companies to enhance technology platform capabilities, providing a comprehensive solution for global partners engaged in the early discovery of next-generation bioconjugates.
Nona Biosciences, expressed enthusiasm about the collaboration, stating, "Leveraging our cutting-edge antibody technologies and extensive experience in antibody research and development, Nona is committed to providing innovative, diverse, and customized solutions for preclinical drug development. We look forward to collaborating with GeneQuantum Healthcare to continuously enhance the capabilities of innovative bioconjugate drug research and development, empowering global partners to advance their ADC drug R&D initiatives."
GeneQuantum Healthcare's Founder and Chairman, Gang Qin, PhD, highlighted the significance of their core technologies, iLDC and iGDC platforms, in addressing challenges prevalent in the ADC field. He emphasized the technologies' ability to reduce production costs, improve drug quality, and enhance global accessibility to ADC drugs. Qin expressed honor in collaborating with Nona Biosciences, stating, "By leveraging GeneQuantum's conjugation technology and Nona's extensive drug development experience, we believe that this collaboration will substantially improve high-quality and high-throughput screening for the early discovery of ADC drugs."
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions! Learn More!